Send mail to Author

HCVerso3 : an open-label, phase IIb study of Faldaprevir and Deleobuvir with Ribavirin in hepatitis C virus genotype-1b-infected patients with cirrhosis and moderate hepatic impairment (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _    __   __   __   _      ___      ______    ______  
| || | ||  \ \\/ // | || | ||   / _ \\   /_   _//  /_   _// 
| || | ||   \ ` //  | '--' ||  / //\ \\    | ||     -| ||-  
| \\_/ ||    | ||   | .--. || |  ___  ||  _| ||     _| ||_  
 \____//     |_||   |_|| |_|| |_||  |_|| /__//     /_____// 
  `---`      `-`'   `-`  `-`  `-`   `-`  `--`      `-----`  
                                                            
 


Back to frontdoor view